Dodecyltrimethylammonium

DB02779ExperimentalSmall molecule

Dodecyltrimethylammonium: Overview.

Mechanism: Pharmacologically active on Tyrosine-protein phosphatase non-receptor type 11
Curator reviewed
Formula / weight: C₁₅H₃₄N · 228.4372 g/mol (avg)
Also known as: Dodecane-trimethylamine · Dodecyl-trimethyl-azanium · Dodecyltrimethylammonium ion · laurtrimonium · laurtrimonium cation

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyVICYBMUVWHJEFT-UHFFFAOYSA-NSMILESCCCCCCCCCCCC[N+](C)(C)C

Targets

What you can answer from here — as of September 19, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dodecyltrimethylammonium, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.